Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic DysfunctionsYubai Zhou, Xiaodong Wang, Kenneth H. Pearce et al.|Journal of Medicinal Chemistry|2022Cited by 31